Fidelity Investments’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $45.9K | Sell |
4,876
-498
| -9% | -$5.47K | ﹤0.01% | 4165 |
|
|
2025
Q4 | $66.7K | Buy |
5,374
+1,327
| +33% | +$17.6K | ﹤0.01% | 3959 |
|
|
2025
Q3 | $58K | Sell |
4,047
-5,692
| -58% | -$78K | ﹤0.01% | 3903 |
|
|
2025
Q2 | $120K | Sell |
9,739
-5,190
| -35% | -$75.4K | ﹤0.01% | 3534 |
|
|
2025
Q1 | $328K | Buy |
14,929
+1,709
| +13% | +$40.2K | ﹤0.01% | 3052 |
|
|
2024
Q4 | $300K | Sell |
13,220
-91,114
| -87% | -$1.99M | ﹤0.01% | 3103 |
|
|
2024
Q3 | $1.9M | Sell |
104,334
-110,076
| -51% | -$2.55M | ﹤0.01% | 2417 |
|
|
2024
Q2 | $6.25M | Buy |
214,410
+166,070
| +344% | +$4.93M | ﹤0.01% | 2009 |
|
|
2024
Q1 | $1.71M | Sell |
48,340
-221,959
| -82% | -$8.88M | ﹤0.01% | 2365 |
|
|
2023
Q4 | $11.8M | Buy |
270,299
+70,257
| +35% | +$2.76M | ﹤0.01% | 1795 |
|
|
2023
Q3 | $7.64M | Buy |
200,042
+143,296
| +253% | +$6.03M | ﹤0.01% | 1916 |
|
|
2023
Q2 | $2.33M | Sell |
56,746
-3,312
| -6% | -$159K | ﹤0.01% | 2284 |
|
|
2023
Q1 | $3.45M | Sell |
60,058
-10,733
| -15% | -$605K | ﹤0.01% | 2217 |
|
|
2022
Q4 | $3.97M | Sell |
70,791
-17,064
| -19% | -$869K | ﹤0.01% | 2181 |
|
|
2022
Q3 | $3.72M | Buy |
87,855
+10,302
| +13% | +$528K | ﹤0.01% | 2252 |
|
|
2022
Q2 | $4.19M | Buy |
77,553
+73,821
| +1,978% | +$4.43M | ﹤0.01% | 2292 |
|
|
2022
Q1 | $240K | Buy |
3,732
+3,272
| +711% | +$215K | ﹤0.01% | 3213 |
|
|
2021
Q4 | $31K | Buy |
460
+77
| +20% | +$5.21K | ﹤0.01% | 3351 |
|
|
2021
Q3 | $26K | Sell |
383
-65,150
| -99% | -$4.6M | ﹤0.01% | 3366 |
|
|
2021
Q2 | $4.47M | Sell |
65,533
-107,826
| -62% | -$7.63M | ﹤0.01% | 2359 |
|
|
2021
Q1 | $12M | Sell |
173,359
-169,014
| -49% | -$11.5M | ﹤0.01% | 1971 |
|
|
2020
Q4 | $22.2M | Sell |
342,373
-292,627
| -46% | -$15.7M | ﹤0.01% | 1675 |
|
|
2020
Q3 | $30M | Sell |
635,000
-6,100
| -1% | -$290K | ﹤0.01% | 1398 |
|
|
2020
Q2 | $30.1M | Sell |
641,100
-101,875
| -14% | -$5.01M | ﹤0.01% | 1378 |
|
|
2020
Q1 | $33.2M | Sell |
742,975
-121,985
| -14% | -$6.4M | ﹤0.01% | 1194 |
|
|
2019
Q4 | $50.4M | Buy |
864,960
+706
| +0.1% | +$42K | 0.01% | 1211 |
|
|
2019
Q3 | $51.9M | Sell |
864,254
-1,656,168
| -66% | -$98.7M | 0.01% | 1151 |
|
|
2019
Q2 | $141M | Sell |
2,520,422
-2,312,766
| -48% | -$119M | 0.02% | 782 |
|
|
2019
Q1 | $269M | Sell |
4,833,188
-1,517,497
| -24% | -$77.3M | 0.03% | 540 |
|
|
2018
Q4 | $286M | Sell |
6,350,685
-5,300,292
| -45% | -$291M | 0.04% | 456 |
|
|
2018
Q3 | $767M | Buy |
11,650,977
+572,857
| +5% | +$35.6M | 0.09% | 211 |
|
|
2018
Q2 | $714M | Buy |
11,078,120
+1,166,483
| +12% | +$72.2M | 0.08% | 229 |
|
|
2018
Q1 | $549M | Buy |
9,911,637
+248,079
| +3% | +$13M | 0.07% | 313 |
|
|
2017
Q4 | $462M | Sell |
9,663,558
-661,678
| -6% | -$32.4M | 0.05% | 375 |
|
|
2017
Q3 | $521M | Buy |
10,325,236
+2,240,674
| +28% | +$115M | 0.06% | 323 |
|
|
2017
Q2 | $441M | Buy |
8,084,562
+468,678
| +6% | +$22.4M | 0.05% | 354 |
|
|
2017
Q1 | $321M | Sell |
7,615,884
-2,956,464
| -28% | -$126M | 0.04% | 486 |
|
|
2016
Q4 | $454M | Buy |
10,572,348
+223,464
| +2% | +$9.08M | 0.06% | 347 |
|
|
2016
Q3 | $427M | Buy |
10,348,884
+581,186
| +6% | +$24.3M | 0.06% | 365 |
|
|
2016
Q2 | $390M | Buy |
9,767,698
+327,200
| +3% | +$11.8M | 0.05% | 387 |
|
|
2016
Q1 | $318M | Sell |
9,440,498
-1,653,974
| -15% | -$51.5M | 0.04% | 451 |
|
|
2015
Q4 | $376M | Buy |
11,094,472
+155,658
| +1% | +$4.87M | 0.05% | 405 |
|
|
2015
Q3 | $326M | Sell |
10,938,814
-1,146,895
| -9% | -$35.9M | 0.05% | 428 |
|
|
2015
Q2 | $333M | Buy |
12,085,709
+57,199
| +0.5% | +$1.52M | 0.04% | 461 |
|
|
2015
Q1 | $303M | Buy |
12,028,510
+1,360,167
| +13% | +$32.2M | 0.04% | 507 |
|
|
2014
Q4 | $236M | Buy |
10,668,343
+167,072
| +2% | +$3.39M | 0.03% | 605 |
|
|
2014
Q3 | $213M | Sell |
10,501,271
-941,157
| -8% | -$18.7M | 0.03% | 632 |
|
|
2014
Q2 | $220M | Sell |
11,442,428
-48,680
| -0.4% | -$907K | 0.03% | 625 |
|
|
2014
Q1 | $216M | Sell |
11,491,108
-122,324
| -1% | -$2.36M | 0.03% | 622 |
|
|
2013
Q4 | $226M | Buy |
11,613,432
+1,303,786
| +13% | +$23.9M | 0.03% | 584 |
|
|
2013
Q3 | $170M | Buy |
10,309,646
+10,725
| +0.1% | +$172K | 0.03% | 695 |
|
|
2013
Q2 | $154M | Buy |
+10,298,921
| New | +$151M | 0.03% | 694 |
|
Other funds holding IART
RCMNY
PCMI
VPM
VCM
Fidelity Investments's IART Position: Q1 2026 in Review
Fidelity Investments reduced its Integra LifeSciences (IART) stake by 9.3% in Q1 2026, selling an estimated $5.47K and leaving 4,876 shares worth $45.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4165.
Fidelity Investments first reported a position in IART in Q2 2013 and has held it in 52 quarters since. The position peaked at $767M in Q3 2018. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.
- Fidelity Investments held 4,876 shares of Integra LifeSciences worth $45.9K as of Q1 2026.
- Fidelity Investments sold 498 Integra LifeSciences shares in Q1 2026, an estimated $5.47K.
- Integra LifeSciences made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #4165 holding.
- Fidelity Investments first reported a position in Integra LifeSciences in Q2 2013 and has held it in 52 quarters since.
- Fidelity Investments's Integra LifeSciences position peaked at $767M in Q3 2018.
- 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.